EPA-625
EPA-625 from Cardiovascular Research is an omega and fish oil supplement designed to provide essential fatty acids. Each serving delivers 1360mg of Fish Oil, a dosage that is considered clinically relevant and commonly used to support cardiovascular health and inflammatory responses. The product has an N+ Score of 77 and a grade of B-, placing it in the 'good' tier according to Nutrienting.com's analysis. With a total of 5 ingredients, the label transparency is good, and its ingredient adequacy is 100% for its primary component. This supplement may be suitable for individuals aiming to increase their intake of beneficial omega-3 fatty acids.
About This Product
EPA-625 by Cardiovascular Research is a omega & fish oil supplement containing 5 active ingredients. It has earned an N+ Score of 77/100 (Grade B-).
This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.
Notable clinical-dose ingredients include Fish Oil.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Key ingredients at clinically effective doses
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +1 ingredient(s) at clinical dose levels
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (5 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Calories | 15.000 Calorie(s) | N/A |
| Total Fat | 1.500 Gram(s) | N/A |
| Cholesterol | 5.000 mg | N/A |
| Fish Oil | 1360.000 mg | Optimal |
| Monounsaturated Fat | — | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.